Epigenetic modification after inhibition of IGF-1R signaling in human central nervous system atypical teratoid rhabdoid tumor (AT/RT)

Child's Nervous System

Volumn 29, Issue 8, 2013, Pages 1245-1251

  Shim, Kyu Won ^a,b   Xi, Guifa ^a   Farnell, Barbara Mania ^d   Kim, Dong Seok ^b   Tsurubuchi, Takao ^a,c   Tomita, Tadanori ^a   Mayanil, C Shekhar ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d PURDUE UNIVERSITY CALUMET   (United States)

Author keywords

Atypical teratoid rhabdoid tumor; Epigenetic modification; Histone acetyl transferase; Histone deacetylase; IGF 1R; Picropodophyllin

Indexed keywords

ANTINEOPLASTIC AGENT; HISTONE ACETYLTRANSFERASE GCN5; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; PICROPODOPHYLLIN; SIRTUIN 1; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CASE REPORT; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CHILD; EPIGENETICS; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOID TUMOR; SIGNAL TRANSDUCTION; TISSUE CULTURE; TISSUES;

EID: 84880836094     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-013-2087-7     Document Type: Article

References (25)

1. Baserga R (1995) The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55(2):249-252
2. Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M (2002) The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 62(1):323-328
3. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8(11):3461-3467
4. Chen YW, Wong TT, Ho DM, Huang PI, Chang KP, Shiau CY, Yen SH (2006) Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys 64(4):1038-1043
5. Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27(3):385-389
6. Gidwani P, Levy A, Goodrich J, Weidenheim K, Kolb EA (2008) Successful outcome with tandem myeloablative chemotherapy and autologous peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 88(2):211-215
7. Glozak MA, Seto E (2007) Histone deacetylases and cancer. Oncogene 26(37):5420-5432
8. Henriksson M, Luscher B (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182
9. Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22(14):2877-2884
10. Karnes PS, Tran TN, Cui MY, Bogenmann E, Shimada H, Ying KL (1991) Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46, XY, t(11;22)(p15.5;q11.23). Cancer Genet Cytogenet 56(1):31-38
11. Maison C, Bailly D, Peters AH, Quivy JP, Roche D, Taddei A, Lachner M, Jenuwein T, Almouzni G (2002) Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat Genet 30(3):329-334
12. Min J, Singh S, Fitzgerald-Bocarsly P, Wood TL (2012) Insulin-like growth factor I regulates G2/M progression through mammalian target of rapamycin signaling in oligodendrocyte progenitors. Glia 60(11):1684-1695
13. Narendran A, Coppes L, Jayanthan A, Coppes M, Teja B, Bernoux D, George D, Strother D (2008) Establishment of atypical-teratoid/rhabdoid tumor (AT/RT) cell cultures from disseminated CSF cells: a model to elucidate biology and potential targeted therapeutics. J Neurooncol 90(2):171-180
14. Nascarella MA, Calabrese EJ (2009) The relationship between the IC(50), toxic threshold, and the magnitude of stimulatory response in biphasic (hormetic) dose-responses. Regulatory Toxicology and Pharmacology: RTP 54(3):229-233
15. Ogino S, Cohen ML, Abdul-Karim FW (1999) Atypical teratoid/rhabdoid tumor of the CNS: cytopathology and immunohistochemistry of insulin-like growth factor-II, insulin-like growth factor receptor type 1, cathepsin D, and Ki-67. Mod Pathol 12(4):379-385
16. Ohshima-Hosoyama S, Hosoyama T, Nelon LD, Keller C (2010) IGF-1 receptor inhibition by picropodophyllin in medulloblastoma. Biochem Biophys Res Commun 399(4):727-732
17. Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 24(5):337-342
18. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, Squire JA, Smith A, Dirks P (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4(6):568-580
19. Rickert CH, Paulus W (2004) Chromosomal imbalances detected by comparative genomic hybridisation in atypical teratoid/rhabdoid tumours. Childs Nerv Syst 20(4):221-224
20. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435(7046):1262-1266
21. Strother D (2005) Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges. Expert Rev Anticancer Ther 5(5):907-915
22. Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A (2005) Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23(7):1491-1499
23. Vinciguerra M, Santini MP, Martinez C, Pazienza V, Claycomb WC, Giuliani A, Rosenthal N (2012) mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 11(1):139-149
24. Wang HJ, Tashiro S, Onodera S, Ikejima T (2008) Inhibition of insulin-like growth factor 1 receptor signaling enhanced silibinin-induced activation of death receptor and mitochondrial apoptotic pathways in human breast cancer MCF-7 cells. J Pharmacol Sci 107(3):260-269
25. Yin S, Girnita A, Stromberg T, Khan Z, Andersson S, Zheng H, Ericsson C, Axelson M, Nister M, Larsson O, Ekstrom TJ, Girnita L (2010) Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma. Neuro Oncol 12(1):19-27